JPY 2186.0
(0.78%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 10.17 Billion | 7.56 Billion | 2.5 Billion | 4.29 Billion | 9.99 Billion | 10.04 Billion |
Net Income | 2.77 Billion | 1.93 Billion | -906 Million | -3.04 Billion | 3.59 Billion | 4.67 Billion |
Depreciation & Amortization | 5.68 Billion | 5.94 Billion | 6.08 Billion | 5.95 Billion | 5.98 Billion | 5.5 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.77 Billion | -359 Million | -2.74 Billion | 1.81 Billion | -20 Million | -1.03 Billion |
Other non-cash items | 10.06 Billion | 38 Million | 73 Million | -428 Million | 438 Million | 896 Million |
Investing Cash Flow | -2.19 Billion | -3.02 Billion | -3.3 Billion | -3.6 Billion | -6.92 Billion | -5.49 Billion |
Investments in PPE | -3.57 Billion | -2.89 Billion | -3.62 Billion | -4.15 Billion | -7.22 Billion | -5.99 Billion |
Acquisitions | 39 Million | -207 Million | -814 Million | 196 Million | 154 Million | -1.64 Billion |
Investment purchases | - | -1 Million | -51 Million | -5 Million | -5 Million | -5 Million |
Sales/Maturities of investments | 1.47 Billion | 223 Million | 298 Million | -196 Million | -154 Million | 330 Million |
Other Investing Activities | -134 Million | -147 Million | 890 Million | 548 Million | 306 Million | 1.82 Billion |
Financing Cash Flow | -7.49 Billion | -5.4 Billion | -715 Million | 1.48 Billion | -3.15 Billion | -4.51 Billion |
Debt repayment | -6.54 Billion | -985 Million | -2.24 Billion | -3.49 Billion | -4.48 Billion | -5.13 Billion |
Dividends payments | -400 Million | - | - | -806 Million | -805 Million | - |
Common Stock Repurchased | -1.93 Billion | -2.03 Billion | - | - | - | - |
Common Stock Issuance | 1.67 Billion | 1.22 Billion | - | - | - | - |
Other Financing Activities | -286 Million | -3.6 Billion | 1.52 Billion | 5.78 Billion | 2.13 Billion | 613 Million |
Accounts receivables | -186 Million | -2.05 Billion | 87 Million | 2.56 Billion | -1.17 Billion | -773 Million |
Accounts payables | 791 Million | 2.99 Billion | -2.36 Billion | -3.98 Billion | 980 Million | -322 Million |
Inventory | 637 Million | 444 Million | 1.11 Billion | 2.26 Billion | -309 Million | -62 Million |
Other working capital | 531 Million | -1.74 Billion | -1.57 Billion | 975 Million | 481 Million | 121 Million |
Cash at beginning of period | 3.24 Billion | 4.1 Billion | 5.61 Billion | 3.44 Billion | 3.53 Billion | 3.49 Billion |
Cash at end of period | 3.72 Billion | 3.24 Billion | 4.1 Billion | 5.61 Billion | 3.44 Billion | 3.53 Billion |
Capital Expenditure | -3.57 Billion | -2.89 Billion | -3.62 Billion | -4.15 Billion | -7.22 Billion | -5.99 Billion |
Effect of forex changes on cash | -1 Million | - | - | 1 Million | -1 Million | -1 Million |
Net cash flow / Change in cash | 485 Million | -861 Million | -1.51 Billion | 2.17 Billion | -83 Million | 33 Million |
Free Cash Flow | 6.59 Billion | 4.67 Billion | -1.12 Billion | 146 Million | 2.77 Billion | 4.05 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 789 Million | 1.24 Billion | 2.77 Billion | 355 Million | 1 Billion | 179 Million |
Depreciation & Amortization | - | - | 5.68 Billion | 1.4 Billion | 1.4 Billion | 1.48 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 1.77 Billion | - | - | - |
Other non-cash items | -789 Million | -1.24 Billion | 10.06 Billion | -355 Million | -1 Billion | -179 Million |
Investing Cash Flow | - | - | -2.19 Billion | - | - | - |
Investments in PPE | - | - | -3.57 Billion | - | - | - |
Acquisitions | - | - | 39 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 1.47 Billion | - | - | - |
Other Investing Activities | - | - | -134 Million | - | - | - |
Financing Cash Flow | - | - | -7.49 Billion | - | - | - |
Debt repayment | - | - | -6.54 Billion | - | - | - |
Dividends payments | - | - | -400 Million | - | - | - |
Common Stock Repurchased | - | - | -1.93 Billion | - | - | - |
Common Stock Issuance | - | - | 1.67 Billion | - | - | - |
Other Financing Activities | - | - | -286 Million | - | - | - |
Accounts receivables | - | - | -186 Million | - | - | - |
Accounts payables | - | - | 791 Million | - | - | - |
Inventory | - | - | 637 Million | - | - | - |
Other working capital | - | - | 531 Million | - | - | - |
Cash at beginning of period | - | - | 3.24 Billion | 2.46 Billion | 2.48 Billion | 3.24 Billion |
Cash at end of period | - | - | 3.72 Billion | 2.76 Billion | 2.46 Billion | 2.48 Billion |
Capital Expenditure | - | - | -3.57 Billion | - | - | - |
Effect of forex changes on cash | - | - | -1 Million | - | - | - |
Net cash flow / Change in cash | - | - | 485 Million | 305 Million | -21 Million | -762 Million |
Free Cash Flow | - | - | 6.59 Billion | 2.81 Billion | 2.81 Billion | 2.96 Billion |
SHO
BAIDFIN
COCKERILL
BUJAW
MEDS
SUDTIND-B